Applicable under the EU-US Trade Agreements or specific derogations for pharmaceutical products if conditions are met (e.g., certification of origin).
Additional Information
No additional information available.
Last updated: 1 year ago
News and Updates
Recent News
US Increases Export of Steroidal Hormones to Martinique
Recent trade data indicates a 20% rise in the export of steroidal hormones and their derivatives (HS Code: 2937) from the United States to Martinique, driven by heightened demand in the pharmaceutical sector.
2023-10-15
Impact: This surge is likely to strengthen trade ties and increase revenue for US exporters, though it may raise concerns about supply chain dependencies for Martinique.
Martinique Importers Face Delays in Steroidal Hormone Shipments from US
Logistical challenges at US ports have led to delays in shipments of steroidal hormones to Martinique, affecting local pharmaceutical production timelines.
2023-09-22
Impact: Delays could disrupt Martinique’s pharmaceutical supply chain, potentially increasing costs for importers and end consumers.
New Trade Agreement Boosts US-Martinique Hormone Trade
A bilateral trade agreement has facilitated smoother export processes for steroidal hormones from the US to Martinique, reducing bureaucratic hurdles.
2023-08-10
Impact: This agreement is expected to enhance trade volumes and foster long-term partnerships between US exporters and Martinique importers.
Policy Updates
US Updates Export Regulations for Steroidal Hormones
The US Department of Commerce has introduced stricter documentation requirements for the export of steroidal hormones (HS Code: 2937) to ensure compliance with international health standards.
Date: 2023-09-01
Martinique Revises Import Tariffs on Pharmaceutical Products
Martinique has reduced import tariffs on steroidal hormones and derivatives by 5% to encourage pharmaceutical trade and support local healthcare needs.
